HOWL Werewolf Therapeutics, Inc.

BEARISH Impact: 5/10 Insider Cluster (2 insiders)
Horizon weeks Filed Jun 12, 2026 Processed 1d 14h ago
Insider cluster: 2 insiders, $156K total

Price Chart

Loading chart...

Executive Summary

Two insiders at Werewolf Therapeutics — a director and a 10% owner — sold a total of ~$156K in open-market sales over two days, representing ~0.87% of the company's $18M market cap. The cluster is wholly in SELL, with no insider buys, and the selling by a major institutional holder (RA Capital) is material relative to issuer size for a sub-$20M market cap.

Key Financial Metrics

Direction
selling
Total Value
$156.4K
Insiders
2

Actionable Insight

The sustained selling by both a board member and the largest institutional holder (RA Capital) in consecutive sessions warrants close monitoring. Check for upcoming 10-Q or 8-K filings (earnings, pipeline update, or financing) that may have triggered the sale. If no positive catalyst emerges, consider that insiders may be reducing exposure ahead of adverse clinical or funding news at this micro-cap biotech.

Key Facts

  • Insider SELL cluster: 2 insiders, 5 trades over 7 days, 100% selling
  • Total open-market sales: ~$156,000
  • 10% owner RA Capital Management sold 633,173 shares (~$237K aggregate in 3 trades) over three days (Jun 8-11 at $0.37-$0.38)
  • Director Luke Evnin sold 76,928 shares at $0.37 on Jun 9 and 60,547 shares at $0.40 on Jun 8
  • No insider purchases in the cluster (zero open-market buys)
  • Sales represent ~0.87% of $18M market cap — above the 0.5% threshold for significance
  • Prior 30d insider activity: 10 sells totaling $372K; the current cluster substantially extends that selling pattern

Financial Impact

$156K open-market insider selling over a 7-day window = 0.87% of market cap

market capinsider ownershipselling pressure

Risk Factors

  • Insider selling cluster before clinical data or funding announcement could foreshadow bad news
  • RA Capital is the largest holder; continued liquidation would further pressure the stock
  • Micro-cap biotech with $18M market cap — high dilution and cash-burn risk; insider sales may signal runway concern

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (10 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-HOWL-1781223262981
12 reports for HOWL
Performance horizon
83% Hit rate 5 of 6 directional calls best @ T+20▲ +37.43%Apr 27, 2026
Filters
Rows
Reports for HOWL — sortable, filterable
Type Now
Jun 12, 2026
1d ago
Insider Cluster
BEARISH ★ 5/10
$0.3938 awaiting T+5awaiting T+5$0.3810 (+3.25%)
May 28, 2026
15d ago
144
BEARISH ★ 6/10
$0.4500 $0.3920▲ +12.89%▲ +10.37%$0.3810 (+15.33%)
May 20, 2026
23d ago
Insider Cluster
NEUTRAL ★ 4/10
$0.4220 $0.4500▲ +6.64%▲ +4.79%$0.3810 (−9.72%)
May 18, 2026
25d ago
144
BEARISH ★ 6/10
$0.4280 $0.4900▼ −14.49%▼ −12.19%$0.3810 (+10.98%)
May 11, 2026
4w ago
144
BEARISH ★ 6/10
$0.6320 $0.4950▲ +21.68%▲ +21.75%$0.3810 (+39.72%)
May 7, 2026
5w ago
Insider Cluster
BEARISH ★ 6/10
$0.6200 $0.5840▲ +5.81%▲ +7.31%$0.3810 (+38.55%)
May 1, 2026
6w ago
144
NEUTRAL ★ 2/10
$0.6900 $0.6610▼ −4.20%▼ −7.14%$0.3810 (−44.78%)
May 1, 2026
6w ago
144
NEUTRAL ★ 4/10
$0.6900 $0.6610▼ −4.20%▼ −7.14%$0.3810 (−44.78%)
May 1, 2026
6w ago
144
BEARISH ★ 5/10
$0.6900 $0.6610▲ +4.20%▲ +7.14%$0.3810 (+44.78%)
Apr 29, 2026
6w ago
144
NEUTRAL ★ 2/10
$0.7200 $0.6200▼ −13.89%▼ −15.62%$0.3810 (−47.08%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (47h 7m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access